Latest University of Texas Health Science Center at San Antonio Stories

2007-08-08 12:09:12

Chris H. M. Takimoto, M.D., Ph.D., an internationally recognized leader in the development of new anti-cancer drugs, has been named director of pharmacology at South Texas Accelerated Research Therapeutics (START). Dr. Takimoto comes to START from the Cancer Therapy & Research Center's Institute for Drug Development, where he was pharmacology director and held the Zachry Chair of Translational Research. START, a clinical research organization focused on developing new anti-cancer...

2007-07-20 12:07:37

SAN ANTONIO, July 20 /PRNewswire/ -- The Cancer Therapy & Research Center Institute for Drug Development, in collaboration with Oncolytics Biotech Inc., a biotechnology company, has enrolled the first two patients in a new Phase II clinical study for patients with various types of sarcomas that have metastasized to the lung. CTRC is one of only three sites in the United States, and the only in Texas, enrolling patients. The novel anti-cancer therapy, REOLYSIN(R), is a living virus, not...

2007-03-20 15:01:02

SAN ANTONIO, March 20 /PRNewswire-USNewswire/ -- San Antonio will be the epicenter of a national change in bicultural health care as Hispanic doctors from across the U.S. meet here March 23-25 to share innovative practices to treat diabetes, obesity, dementia and other diseases affecting Latinos. The doctors are attending the 11th annual conference of the National Hispanic Medical Association (NHMA), a nonprofit group based in Washington, D.C., that represents Hispanic physicians in the...

Word of the Day
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.